BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, January 19, 2026
Home » Authors » David Ho

David Ho

Articles

ARTICLES

China FDA boosts supervision for imported drugs

June 13, 2017
By David Ho

HONG KONG – The CFDA has, over the last few years, multiplied supervision of imported pharmaceuticals while speeding up local drug reviews.


Read More

Biologics Boom: Wuxi's $510M HK IPO denotes growing Asian sector

June 9, 2017
By David Ho
HONG KONG – The heavily oversubscribed Hong Kong IPO by Wuxi Biologics, is underscoring a promising outlook for biotech companies in Asia.
Read More

Saudi Arabia boosts drug manufacturing to grow pharma sector

May 17, 2017
By David Ho
HONG KONG – Saudi Arabia is emerging as a powerhouse for drug production.
Read More

Saudi Arabia boosts drug manufacturing to grow pharma sector

May 17, 2017
By David Ho
HONG KONG – Saudi Arabia is emerging as a powerhouse for drug production. Case in point is a newly built 75,000-square-meter drug manufacturing facility in the country’s King Abdulla Economic City.
Read More

Malaysia launches health data sharing platform

May 16, 2017
By David Ho

Japan invited to invest in 'Make in India'

May 11, 2017
By David Ho

India rejects requests from Abbott, Medtronic to take stents off market

April 28, 2017
By David Ho

Sanofi's dengue vaccine cleared for conditional 2-year trial in Malaysia

April 26, 2017
By David Ho
HONG KONG – Sanofi Pasteur Ltd.'s dengue vaccine has been granted a conditional registration for two years in Malaysia while phase IV studies are carried out.
Read More

Cardiology companies taking Asia's cardio needs to heart, struggling to keep pace

April 25, 2017
By David Ho

Sanofi's dengue vaccine cleared for conditional 2-year trial In Malaysia

April 24, 2017
By David Ho
HONG KONG – Sanofi Pasteur Ltd.'s dengue vaccine has been granted a conditional registration for two years in Malaysia while phase IV studies are carried out.
Read More
View All Articles by David Ho

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 16, 2026.
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • Businesswoman pressing dollar sign on touchscreen

    JPM 2026: Year kicks off with biopharma Q4 revenue and guidance

    BioWorld
    It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing